Phil Falkowitz's Clinical Trial Experience Is Featured in Journal Article


PMMNG member Phil Falkowitz started taking Revlimid (lenalidomide) way back in 2001, during the Phase 1 clinical trial of Revlimid. That trial went well for him (and for Revlimid). Phil's experience related to the clinical trial is described in a recent Journal of Clinical Research Best Practices article. Phil still takes Revlimid, and now has been taking it the second longest of anyone in the world.